| |
| Device | Eversense Continuous Glucose Monitoring System |
| Generic Name | Continuous glucose monitor, implanted, adjunctive use |
| Applicant | Senseonics, Incorporated 20451 Seneca Meadows Pkwy. Germantown, MD 20876 |
| PMA Number | P160048 |
| Supplement Number | S008 |
| Date Received | 12/11/2018 |
| Decision Date | 01/28/2019 |
| Product Code |
QCD |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT02154126
|
| Supplement Type | Real-Time Process |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval to label the Eversense Sensor as Magnetic Resonance (MR) Conditional. |
| Post-Approval Study | Show Report Schedule and Study Progress |